CXCL13 shapes tumor immune microenvironment in ovarian cancer with homologous recombination deficiency
Yue Ding,
Zheng Ye,
Bo Ding,
Songwei Feng,
Furong Du,
Xuejiao Ma,
Xiaoxuan Wang,
Yang Shen
Affiliations
Yue Ding
Department of Obstetrics and Gynaecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210008, China
Zheng Ye
State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu 210096, China
Bo Ding
Department of Obstetrics and Gynaecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210008, China
Songwei Feng
Department of Obstetrics and Gynaecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210008, China
Furong Du
State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, Jiangsu 210042, China
Xuejiao Ma
State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, Jiangsu 210042, China
Xiaoxuan Wang
State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, Jiangsu 210042, China
Yang Shen
Department of Obstetrics and Gynaecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210008, China; Corresponding author.
